NATH BIO-GENES (INDIA) LTD.
NSE : NATHBIOGENBSE : 537291ISIN
CODE : INE448G01010Industry : AgricultureHouse
: Private
BSE207.207.65 (+3.83 % )
PREV CLOSE (Rs.) 199.55
OPEN PRICE (Rs.) 200.90
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 8717
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE207.40 7.3 (+3.65 % )
PREV CLOSE(Rs.) 200.10
OPEN PRICE (Rs.) 201.00
BID PRICE (QTY) 207.40 (24 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 95901
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Company News
| Date | Heading | Details |
|---|---|---|
| 15-Apr-2024 | Nath Bio-Genes (India) informs about compliances-certificate | <div style="text-align: justify;">In Compliance with the requirement under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, Nath Bio-Genes (India) has informed that the ‘Compliance Certificate' for the quarter ended 31st March 2024 received from Bigshare Services, Registrar and Share Transfer Agent of the Company.</div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div> |
| 12-Apr-2024 | Nath Bio-Genes (India) informs about compliance certificate | <div>Nath Bio-Genes (India) has informed that it enclosed the ‘Compliance Certificate' for the financial year ended 31st March, 2024. The Certificate dated 12th April, 2024 has been signed and issued as per the referred regulation.</div><div><br></div><div>The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 15-Mar-2024 | Nath Bio-Genes (India) informs about EGM | <div>Nath Bio-Genes (India) has informed that the EGM of the Members of the Company was held on Tuesday 12th March 2024 at 11:00 am via video conferencing/other audio-visual means.</div><div><br></div><div>The above information is a part of company's filings submitted to BSE.</div><div><br></div> |
| 22-Feb-2024 | Nath Bio-Genes (India) informs about disclosure | <p style="text-align: justify;">Nath Bio-Genes (India) has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Agri-Tech (India).</p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</p> |
| 22-Dec-2023 | Nath Bio-Genes (India) informs about disclosure | <p style="text-align: justify;">Nath Bio-Genes (India) has informed that it enclsoed the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Akash Farms LLP.</p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</p> |
| 12-Dec-2023 | Nath Bio-Genes (India) informs about disclosure | <p style="text-align: justify;">Nath Bio-Genes (India) has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Agri- Tech (India).</p><div>The above information is a part of company's filings submitted to BSE.</div> |
| 21-Oct-2023 | Nath Bio-Genes (India) informs about conference call | <p style="text-align: justify;">Nath Bio-Genes (India) has informed that the Company had organized a conference call with the Investors/Analysts on Tuesday 17th October, 2023, post declaration of its Unaudited financial results for the quarter and half year ended 30th September 2023. A copy of transcript of conference call held with Investors/Analysts is enclosed and the same being uploaded on Company's website.</p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</p> |
| 17-Jun-2023 | Nath Bio-Genes (India) informs about AGM | <div style="text-align: justify;">Nath Bio-Genes (India) has informed that it enclosed Notice of the 30th Annual General Meeting (AGM) of the Company along with the Integrated Annual Report of the Company for the financial year 2022-23, which is being sent to the shareholders by electronic mode. The 30th Annual General Meeting of the Company will be held on Tuesday, July 11, 2023 at 11.00 am through Video Conferencing/ Other Audio Visual means (VC/OAVM). Pursuant to Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management And Administration) Rules, 2014 and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company is pleased to provide its members with the remote e-voting facility to cast their votes electronically on the resolutions mentioned in the AGM Notice using the electronic voting platform provided by National Securities Depository (NSDL). The voting rights of members shall be in proportion to the shares held by them, as on the cut-off date, Friday. June 30, 2023.<span style="white-space: pre;"> </span></div><div style="text-align: justify;"><br></div><div style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</div><div style="text-align: justify;"><br></div> |
| 23-May-2023 | Nath Bio-Genes (India) informs about change in date of AGM and book closure | <p style="text-align: justify;">With reference to earlier intimation dated 22nd April 2023, under heading Outcome of Board Meeting, Nath Bio-Genes (India) has informed that the Annual General Meeting (AGM) of the Company is rescheduled on Tuesday, 11th July 2023 by Audio Visual Means due to Operational Reasons. Accordingly, the registrar of members and share transfer book of the Company will be closed from 05th July 2023 to 11th July 2023 for the purpose of holding Annual General Meeting and determining entitlement of the members for Dividend (Annexure). The record date is 30th June 2023 for the purpose of AGM and Dividend. Detailed Notice of Annual General Meeting and Annual Report will be submitted separately.</p><p style="text-align: justify;">The above information is a part of company's filings submitted to BSE.</p> |
